EFFECT ·Filed Jul 16, 2026

CHRN

ChronoScale Holdings Corp
NEUTRAL
Impact 3/10
Horizonweeks Processed2mo ago SEC9999999995-26-002314
IPO/offering going effective
Actionable Insight • Neutral

Monitor for any Form 144 filings or trading volume spikes indicating selling by the registered stockholders. The overhang is modest but could create near-term headwinds, especially given the company's loss-making status. No immediate catalyst from this procedural step.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+20d
CHRN ▼ -19.80% at T+20d
NEUTRAL call ✗ call lost -19.80% · α vs SPY -23.42% · entry $25.71 → $20.62
Next anchor: T+60d in 7d
Latest observation: T+52 -88.88% FF3 residual α
Entry anchored
Jul 15, 04:27 PM ET
via exchange tick
T+1d
+2.80%
call +2.80% · α +3.79%
$26.43
settled 3mo ago
T+5d
-12.21%
call -12.21% · α -10.54%
$22.57
settled 2mo ago
T+20d
-19.80%
call -19.80% · α -23.42%
$20.62
settled 7w ago
T+60d
—
call — · α —
—
in 7d

Price Chart

Loading chart...

Executive Summary

ChronoScale's S-3 registration statement (File No. 333-297176) became effective on July 15, 2026, enabling the resale of 1,097,509 shares by selling stockholders (Lake Street, Daniel Asher Trust, Hood River) from prior private placements. The company receives no proceeds from these sales, and the shares represent a modest ~0.8% of outstanding, but the effectiveness introduces a potential overhang that could weigh on the stock.

Key Facts

  • S-3 registration became effective on 2026-07-15, allowing resale of 1,097,509 shares by selling stockholders.
  • Company receives no proceeds from the resale; shares stem from prior private placements.
  • Shares represent approximately 0.8% of outstanding, a modest dilution overhang.
  • Company has ongoing losses and may need additional capital, though this filing does not raise any.

Financial Impact

Potential selling pressure from ~0.8% of shares outstanding; no immediate financial impact to the company.

dilution

Risk Factors

  • Selling stockholders may begin disposing shares, creating downward pressure on CHRN stock.
  • Company's ongoing losses and capital needs may lead to additional dilutive offerings in the future.

Market Snapshot

Exchange
Nasdaq
Analyst Consensus
75% bullish (8 analysts)

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
EFFECT Filing (Primary)9999999995-26-002314
Document: 9999999995-26-002314-index.html9999999995-26-002314
Document: 9999999995-26-002314.txt9999999995-26-002314
6 reports for CHRN
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for CHRN — sortable, filterable
TypeNow
Aug 18, 2026
6w ago
8-K
NEUTRAL ★ 2/10
$23.70 $20.13▼ −15.06%▼ −13.11%$19.21 (−18.95%)
Jul 16, 2026
11w ago
EFFECT
NEUTRAL ★ 3/10
$25.71 $20.62▼ −19.80%▼ −23.42%$19.21 (−25.28%)
Jun 30, 2026
13w ago
S-3
NEUTRAL ★ 4/10
$17.64 $18.52▲ +4.99%▲ +7.17%$19.21 (+8.90%)
Jun 30, 2026
13w ago
8-K
NEUTRAL ★ 3/10
$17.64 $18.52▲ +4.99%▲ +7.17%$19.21 (+8.90%)
Jun 26, 2026
14w ago
8-K
NEUTRAL ★ 4/10
$22.86 $21.50▼ −5.95%▼ −5.67%$19.21 (−15.97%)
Jun 4, 2026
17w ago
8-K
BEARISH ★ 6/10
$19.03 $18.25▲ +4.10%▲ +5.96%$19.21 (−0.95%)
Showing 6 of 6

US Market Status

Market Closed — Opens Mon (64h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access